Riprazo

RSS

aliskiren

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for Riprazo has been withdrawn at the request of the marketing-authorisation holder.

This EPAR was last updated on 01/03/2013

Authorisation details

Product details
Name
Riprazo
Agency product number
EMEA/H/C/000853
Active substance
aliskiren
International non-proprietary name (INN) or common name
aliskiren
Therapeutic area (MeSH)
Hypertension
Anatomical therapeutic chemical (ATC) code
C09XA02
Publication details
Marketing-authorisation holder
Novartis Europharm Ltd.
Revision
8
Date of issue of marketing authorisation valid throughout the European Union
22/08/2007
Contact address
Novartis Europharm Limited
Wimblehurst Road
Horsham
West Sussex, RH12 5AB
United Kingdom

Product information

17/08/2012 Riprazo - EMEA/H/C/000853 - IG/0209/G

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Agents acting on the renin angiotensin system

Therapeutic indication

Treatment of essential hypertension.

Assessment history

How useful was this page?

Add your rating